AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo

AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo

Source: 
Pharmaforum
snippet: 

AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion.